Mitotic index to predict breast cancer recurrence after neoadjuvant systemic therapy.

被引：1
|
作者：
Farrugia, Daniel J.
Landmann, Alessandra
Diego, Emilia
McAuliffe, Priscilla F.
Johnson, Ronald
Bonaventura, Marguerite
Soran, Atilla
Dabbs, David J.
Clark, Beth
Puhalla, Shannon
Brufsky, Adam
Jankowitz, Rachel Catherine
Lembersky, Barry C.
Davidson, Nancy E.
Ahrendt, Gretchen M.
Bhargava, Rohit
机构：
[1] Natl Taiwan Univ, Ctr Genom Med, Taipei, Taiwan
[2] Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan
[3] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e23265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23265
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
    van der Noordaa, M. E.
    Peeters, M-J M. Vrancken
    Ioan, I.
    Loo, C. E.
    van Urk, J.
    van Werkhoven, E.
    Voorthuis, R.
    Wiersma, T.
    Groen, E.
    Rutgers, E. T.
    van Duijnhoven, F. H.
    CANCER RESEARCH, 2019, 79 (04)
  • [32] The approach of combination of breast cancer therapy using the intraoperative radiation therapy after neoadjuvant systemic therapy
    Manikhas, A.
    Grinev, I.
    Oganesyan, A.
    Lee, L.
    Chikrizov, S.
    Manikhas, G.
    BREAST, 2017, 32 : S73 - S73
  • [33] Utilization of neoadjuvant systemic therapy (NST) for breast cancer
    Mohiuddin, Jahan J.
    Deal, Allison Mary
    Carey, Lisa A.
    Lund, Jennifer Leigh
    Baker, Brock R.
    Zagar, Timothy M.
    Jones, Ellen
    Marks, Lawrence Bruce
    Chen, Ronald C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Patterns of failure according to breast cancer subtype after RT and contemporary systemic therapy.
    Ippolito, E.
    Silipigni, S.
    Di Donato, A.
    Petrianni, G.
    Matteucci, P.
    Molfese, E.
    Sicilia, A.
    Trodella, L.
    D'Angellillo, R.
    Ramella, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S724 - S725
  • [35] Neoadjuvant systemic therapy in breast cancer: Challenges and uncertainties
    van de Wiel, Mick
    Dockx, Yanina
    Van den Wyngaert, Tim
    Stroobants, Sigrid
    Tjalma, Wiebren A. A.
    Huizing, Manon T.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 210 : 144 - 156
  • [36] Neoadjuvant systemic therapy and the surgical management of breast cancer
    Waljee, Jennifer F.
    Newman, Lisa A.
    SURGICAL CLINICS OF NORTH AMERICA, 2007, 87 (02) : 399 - +
  • [37] Impact of neoadjuvant systemic therapy on sTIL in breast cancer
    Armaghani, Avan
    Asirvatham, Ruth
    Mramba, Lazarus
    Daily, Karen
    CANCER RESEARCH, 2018, 78 (04)
  • [38] Systemic neoadjuvant therapy of luminal breast cancer in 2016
    Cottu, Paul H.
    BULLETIN DU CANCER, 2017, 104 (01) : 69 - 78
  • [39] Neoadjuvant systemic therapy for breast cancer: the Westmead experience
    Cocco, Annelise M.
    Messer, David
    Brown, Alexander
    Sriram, Nina
    Gilchrist, Jenny
    Al-Mansouri, Loma
    Kefford, Richard
    Meybodi, Farid
    French, James
    Hsu, Jeremy
    Elder, Elisabeth
    ANZ JOURNAL OF SURGERY, 2018, 88 (06) : 640 - 644
  • [40] Comparison of locoregional recurrence in triple-negative and HER2-positive breast cancer subtype after breast-conserving therapy and modern systemic therapy.
    Takita, C.
    Reis, I. M.
    Miao, F.
    LaFave, K. E.
    Gunaseelan, V.
    Hurley, J.
    Silva, O. E.
    Avisar, E.
    Wright, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
12345